Literature DB >> 16567698

Risk factors for transitions from normal to mild cognitive impairment and dementia.

R J Kryscio1, F A Schmitt, J C Salazar, M S Mendiondo, W R Markesbery.   

Abstract

OBJECTIVE: To identify risk factors associated with transitions from cognitively normal to various forms of mild cognitive impairment (MCI) and then from MCI into early dementia with death as a competing state.
METHODS: Cognitive assessments from 554 subjects participating in a longitudinal study at the University of Kentucky AD Center were used to classify individuals into one of three transient states at any visit: cognitively normal, amnestic MCI, or mixed MCI. Between visits subjects could die or become demented. A series of polytomous logistic models were used to model transitions among these states over time and to determine how the log odds of these transitions vary with age, education, sex, family history of dementia, and APOE status.
RESULTS: Age affects all transitions among transient states as well as those to dementia or death. Presence of at least one apolipoprotein 4 allele affects transitions from cognitively normal into amnestic MCI or into dementia. At most 12 years of education affects transitions into mixed MCI. Transitions do not vary with sex or family history.
CONCLUSION: Aside from age, the usual risk factors associated with conversion from cognitively normal into dementia are likely risk factors for transitions into mild cognitive impairment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16567698     DOI: 10.1212/01.wnl.0000203264.71880.45

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  51 in total

Review 1.  Neuropsychological contributions to the early identification of Alzheimer's disease.

Authors:  Mark W Bondi; Amy J Jak; Lisa Delano-Wood; Mark W Jacobson; Dean C Delis; David P Salmon
Journal:  Neuropsychol Rev       Date:  2008-03-18       Impact factor: 7.444

Review 2.  Contributions of neuropsychology and neuroimaging to understanding clinical subtypes of mild cognitive impairment.

Authors:  Amy J Jak; Katherine J Bangen; Christina E Wierenga; Lisa Delano-Wood; Jody Corey-Bloom; Mark W Bondi
Journal:  Int Rev Neurobiol       Date:  2009       Impact factor: 3.230

3.  A multistate model of cognitive dynamics in relation to resistance training: the contribution of baseline function.

Authors:  Nader Fallah; Chun L Hsu; Niousha Bolandzadeh; Jennifer Davis; B Lynn Beattie; Peter Graf; Teresa Liu-Ambrose
Journal:  Ann Epidemiol       Date:  2013-07-03       Impact factor: 3.797

4.  Heterogeneity of cognitive trajectories in diverse older persons.

Authors:  Dan Mungas; Laurel Beckett; Danielle Harvey; Sarah Tomaszewski Farias; Bruce Reed; Owen Carmichael; John Olichney; Joshua Miller; Charles DeCarli
Journal:  Psychol Aging       Date:  2010-09

5.  Effect of common neuropathologies on progression of late life cognitive impairment.

Authors:  Lei Yu; Patricia A Boyle; Sue Leurgans; Julie A Schneider; Richard J Kryscio; Robert S Wilson; David A Bennett
Journal:  Neurobiol Aging       Date:  2015-04-22       Impact factor: 4.673

Review 6.  Huperzine A for mild cognitive impairment.

Authors:  Jirong Yue; Bi Rong Dong; Xiufang Lin; Ming Yang; Hong Mei Wu; Taixiang Wu
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

7.  University of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology.

Authors:  Frederick A Schmitt; Peter T Nelson; Erin Abner; Stephen Scheff; Gregory A Jicha; Charles Smith; Gregory Cooper; Marta Mendiondo; Deborah D Danner; Linda J Van Eldik; Allison Caban-Holt; Mark A Lovell; Richard J Kryscio
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

8.  Prevention of progression to dementia in the elderly: rationale and proposal for a health-promoting memory consultation (an IANA Task Force).

Authors:  S Gillette Guyonnet; G Abellan Van Kan; S Andrieu; J P Aquino; C Arbus; J P Becq; C Berr; S Bismuth; B Chamontin; T Dantoine; J F Dartigues; B Dubois; B Fraysse; T Hergueta; H Hanaire; C Jeandel; S Lagleyre; F Lala; F Nourhashemi; P J Ousset; F Portet; P Ritz; P Robert; Y Rolland; C Sanz; M Soto; J Touchon; B Vellas
Journal:  J Nutr Health Aging       Date:  2008-10       Impact factor: 4.075

9.  The APOE epsilon4 allele is associated with incident mild cognitive impairment among community-dwelling older persons.

Authors:  Patricia A Boyle; Aron S Buchman; Robert S Wilson; Jeremiah F Kelly; David A Bennett
Journal:  Neuroepidemiology       Date:  2009-11-11       Impact factor: 3.282

10.  Effect of APOE genotype status on targeted clinical trials outcomes and efficiency in dementia and mild cognitive impairment resulting from Alzheimer's disease.

Authors:  Richard E Kennedy; Gary R Cutter; Lon S Schneider
Journal:  Alzheimers Dement       Date:  2013-05-25       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.